CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-07 | McLaughlin Brian F Vice President | Grant or award · Nonqualified Stock Option (Right to Buy) | +15,927 | $10.12 | $161K | 15,927 |
| 2020-01-07 | McLaughlin Brian F Vice President | Grant or award · Incentive Stock Option (Right to Buy) | +9,073 | $10.12 | $92K | 25,000 |
| 2020-01-07 | Hall James G Vice President | Grant or award · Nonqualified Stock Option (Right to Buy) | +82,100 | $10.12 | $831K | 82,100 |
| 2020-01-07 | Hall James G Vice President | Grant or award · Incentive Stock Option (Right to Buy) | +17,900 | $10.12 | $181K | 100,000 |
| 2019-11-12 | PANKOPF TONIA L Director | Exercise or conversion | +3,333 | $9.01 | $30K | 36,037 |
| 2019-11-12 | PANKOPF TONIA L Director | Exercise or conversion · Nonstatutory Stock Option (Right to Buy) | −3,333 | $9.01 | $30K | 0 |
| 2019-11-06 | Bolles Albert D. Chief Executive Officer | Purchase | +850 | $10.91 | $9K | 26,152 |
| 2019-11-05 | Bolles Albert D. Chief Executive Officer | Purchase | +3,800 | $10.69 | $41K | 25,302 |
| 2019-11-05 | OBUS NELSON Director | Purchase | +10,000 | $10.38 | $104K | 2,870,300 |
| 2019-10-31 | Burgess Timothy P Senior VP of Supply Chain | Purchase | +5,100 | $9.74 | $50K | 5,100 |
| 2019-10-16 | Tobin Robert Director | Grant or award | +6,000 | $9.18 | $55K | 64,117 |
| 2019-10-16 | Tobin Robert Director | Exercise or conversion · Restricted Stock Unit | −6,000 | 0 | ||
| 2019-10-15 | PANKOPF TONIA L Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | MACALUSO CHARLES Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +5,501 | 5,501 | ||
| 2019-10-15 | Carosella Deborah D Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | OBUS NELSON Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | Sohn Catherine A. Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | FRANK FRED Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | Powell Andrew Kenneth William Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +2,200 | 2,200 | ||
| 2019-10-15 | HOUDE LOVAS KATRINA Director | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +7,334 | 7,334 |
Page 18 of 27 · 528 trades